188 related articles for article (PubMed ID: 9202251)
1. Osteopontin expression by osteoclast and osteoblast progenitors in the murine bone marrow: demonstration of its requirement for osteoclastogenesis and its increase after ovariectomy.
Yamate T; Mocharla H; Taguchi Y; Igietseme JU; Manolagas SC; Abe E
Endocrinology; 1997 Jul; 138(7):3047-55. PubMed ID: 9202251
[TBL] [Abstract][Full Text] [Related]
2. Human osteoclast and giant cell differentiation: the apparent switch from nonspecific esterase to tartrate resistant acid phosphatase activity coincides with the in situ expression of osteopontin mRNA.
Connor JR; Dodds RA; James IE; Gowen M
J Histochem Cytochem; 1995 Dec; 43(12):1193-201. PubMed ID: 8537635
[TBL] [Abstract][Full Text] [Related]
3. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
[TBL] [Abstract][Full Text] [Related]
4. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2.
Rickard DJ; Sullivan TA; Shenker BJ; Leboy PS; Kazhdan I
Dev Biol; 1994 Jan; 161(1):218-28. PubMed ID: 8293874
[TBL] [Abstract][Full Text] [Related]
5. Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures.
Malaval L; Modrowski D; Gupta AK; Aubin JE
J Cell Physiol; 1994 Mar; 158(3):555-72. PubMed ID: 8126078
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin antisense deoxyoligonucleotides inhibit bone resorption by mouse osteoclasts in vitro.
Tani-Ishii N; Tsunoda A; Umemoto T
J Periodontal Res; 1997 Aug; 32(6):480-6. PubMed ID: 9379315
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures.
Leboy PS; Beresford JN; Devlin C; Owen ME
J Cell Physiol; 1991 Mar; 146(3):370-8. PubMed ID: 2022691
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase.
Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K
J Bone Miner Res; 1996 Jan; 11(1):62-71. PubMed ID: 8770698
[TBL] [Abstract][Full Text] [Related]
9. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
[TBL] [Abstract][Full Text] [Related]
10. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts.
Takeshita S; Kaji K; Kudo A
J Bone Miner Res; 2000 Aug; 15(8):1477-88. PubMed ID: 10934646
[TBL] [Abstract][Full Text] [Related]
12. Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces: an in vitro and ex vivo study of remodeling bone.
Dodds RA; Connor JR; James IE; Rykaczewski EL; Appelbaum E; Dul E; Gowen M
J Bone Miner Res; 1995 Nov; 10(11):1666-80. PubMed ID: 8592943
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone-related protein is required for normal intramembranous bone development.
Suda N; Baba O; Udagawa N; Terashima T; Kitahara Y; Takano Y; Kuroda T; Senior PV; Beck F; Hammond VE
J Bone Miner Res; 2001 Dec; 16(12):2182-91. PubMed ID: 11760831
[TBL] [Abstract][Full Text] [Related]
14. The Fas/Fas ligand system inhibits differentiation of murine osteoblasts but has a limited role in osteoblast and osteoclast apoptosis.
Kovacić N; Lukić IK; Grcević D; Katavić V; Croucher P; Marusić A
J Immunol; 2007 Mar; 178(6):3379-89. PubMed ID: 17339432
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation.
Boissy P; Andersen TL; Abdallah BM; Kassem M; Plesner T; Delaissé JM
Cancer Res; 2005 Nov; 65(21):9943-52. PubMed ID: 16267019
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid induces osteoclast-like cell formation by directly acting on hemopoietic blast cells and stimulates osteopontin mRNA expression in isolated osteoclasts.
Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K
Life Sci; 1995; 56(22):1903-13. PubMed ID: 7746099
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of osteoblast precursor cells from human bone marrow.
Rickard DJ; Kassem M; Hefferan TE; Sarkar G; Spelsberg TC; Riggs BL
J Bone Miner Res; 1996 Mar; 11(3):312-24. PubMed ID: 8852942
[TBL] [Abstract][Full Text] [Related]
18. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin.
Lee SK; Goldring SR; Lorenzo JA
Endocrinology; 1995 Oct; 136(10):4572-81. PubMed ID: 7664679
[TBL] [Abstract][Full Text] [Related]
19. Changes in biological activity of bone cells in ovariectomized rats revealed by in situ hybridization.
Ikeda T; Yamaguchi A; Yokose S; Nagai Y; Yamato H; Nakamura T; Tsurukami H; Tanizawa T; Yoshiki S
J Bone Miner Res; 1996 Jun; 11(6):780-8. PubMed ID: 8725175
[TBL] [Abstract][Full Text] [Related]
20. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
